Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Lobesity Investors
AddedFeb 18, 2024
UpdatedJun 18, 2026
Lobesity Investors

Lobesity Investors

Seed

Beachwood-based Lobesity Investors develops innovative pharmaceutical solutions for obesity and related disorders.

HQ
Beachwood, OH, US
Founded
2015
Overview
Compare
Fundraising
Employees

Lobesity Investors, based in Beachwood, Ohio, is dedicated to developing innovative pharmaceutical solutions for obesity and related disorders. The company focuses on creating therapies that address the root causes of obesity, aiming to improve patient health and quality of life.

Lobesity Investors has made significant strides in the pharmaceutical industry by advancing treatments that target obesity. Their work has the potential to impact millions of individuals struggling with weight-related health issues, positioning them as a leader in obesity treatment innovation.

Lobesity Investors - Similar Companies

EndoMetabolic Solutions logo

EndoMetabolic Solutions

endometabolic.com

Lipidio Pharmaceuticals logo

Lipidio Pharmaceuticals

lipidiopharma.com

Eolo Pharma logo

Eolo Pharma

eolo-pharma.com

Woolsey Pharmaceuticals logo

Woolsey Pharmaceuticals

woolseypharma.com

LB Pharmaceuticals logo

LB Pharmaceuticals

lbpharma.us

Satiety logo

Satiety

Elcelyx Therapeutics logo

Elcelyx Therapeutics

Xeno Biosciences logo

Xeno Biosciences

twenty30 health logo

twenty30 health

twenty30.health

Energesis Pharmaceuticals logo

Energesis Pharmaceuticals

Adipogenix logo

Adipogenix

Resolvyx Pharmaceuticals logo

Resolvyx Pharmaceuticals

Commerce Health Ventures logo

Commerce Health Ventures

Adipo Therapeutics logo

Adipo Therapeutics

Theracos logo

Theracos

theracos.com

Lobesity Investors - Quick Facts

Who are Lobesity Investors' competitors?

Companies similar to Lobesity Investors include EndoMetabolic Solutions, Lipidio Pharmaceuticals, Eolo Pharma and Woolsey Pharmaceuticals.

When was Lobesity Investors founded?

Lobesity Investors was founded in 2015.

Where is Lobesity Investors' headquarters located?

Lobesity Investors' headquarters is located in Beachwood, OH, US.

When was Lobesity Investors' last funding round?

Lobesity Investors' most recent funding round was for $722.5k (USD) in July 2015.

How much has Lobesity Investors raised to-date?

As of Jul 28, 2015, Lobesity Investors has raised a total of $722.5k (USD).

How many employees does Lobesity Investors have?

Lobesity Investors has 30 employees as of Feb 5, 2024.

Lobesity Investors - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 13 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research